All Type of News
KPhA stressed importance of pharmacy specialization.
To cope with upcoming implementation of the medical and pharmacy separation system, the KPhA pointed out that each pharmacy should accept the separation system in positive attitude and exert more efforts for preparati...
KPMA asked for drug price slash to suspend
The Drug Trade Order Subcommittee of KPMA decided in the meeting on Sept. 20 to raise a recommendation to the MOHW about one or two month suspension of the overall drug price cut since many drug companies needed inter...
Investment efficiency of new drug R&D enhanced by out-sourcing
The commercialization of the first domestic new drug strongly motivated local pharmaceutical industry to seek enhancement of efficiency in new drug R&D investment by means of utilizing the third party resource in thei...
Medical and pharmacy separation plan finally settled.
The Separation Executive Commission of MOHW took the 2nd meeting and finally concluded the separation plans proposed by the relevant subcommittees including the scope of medical institutes and patients, the methods of...
National Assembly's inspection of government offices scheduled from Sept. 29.
The Health Welfare Commission of the National Assembly (Chief commissioner: Mr. Kim Chan-woo) took the joint meeting of the ruling and opposition party members on Sept. 16 and determined the inspection sched...
Separation plan to be finalized on Sept. 17.
All subcommittees of Separation Implementation Commission have almost completed to prepare the frameworks of the medical and pharmacy separation plan, and therefore the Commission will have the 2nd meeting at the conf...
Drug circles urged conglomerates not to enter small/medium industrial business.
3 big drug related associations, KPMA, KPWA and KPA announced a joint statement to the conglomerates as saying "The conglomerates should stop entering the small and medium sized industrial business but do their best f...
Drug price and medical reimbursement price adjusted simultaneously.
The 21st century forum of the KPMA concluded in their meeting on Sept. 13 and raised clear requests to the government that the issues of drug price reduction (30.7% on average) and the medical reimbursement price incr...
Green Cross acquired 7.3% shares of Sang-A
Green Cross purchased a massive portion of Sang-A's shares to become the 2nd majority shareholder. Sang-A pharmaceutical company was bankrupted and now under the court management control.
Green Cross bought 48,690 st...
Special notification to enact against unfair trade practice on insurance drugs.
The KPMA proposed to the Fair Trade Commission to legislate a special provision for blockading unfair drug trade practices such as an internal drug purchasing contract made between the hospital and the drug supplier s...
